158 related articles for article (PubMed ID: 8679358)
1. Effect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans.
Ilkjaer S; Petersen KL; Brennum J; Wernberg M; Dahl JB
Br J Anaesth; 1996 Jun; 76(6):829-34. PubMed ID: 8679358
[TBL] [Abstract][Full Text] [Related]
2. Effect of systemic N-methyl-D-aspartate receptor antagonist (dextromethorphan) on primary and secondary hyperalgesia in humans.
Ilkjaer S; Dirks J; Brennum J; Wernberg M; Dahl JB
Br J Anaesth; 1997 Nov; 79(5):600-5. PubMed ID: 9422898
[TBL] [Abstract][Full Text] [Related]
3. Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery.
Stubhaug A; Breivik H; Eide PK; Kreunen M; Foss A
Acta Anaesthesiol Scand; 1997 Oct; 41(9):1124-32. PubMed ID: 9366932
[TBL] [Abstract][Full Text] [Related]
4. Effect of oral ketamine on secondary hyperalgesia, thermal and mechanical pain thresholds, and sedation in humans.
Mikkelsen S; Jørgensen H; Larsen PS; Brennum J; Dahl JB
Reg Anesth Pain Med; 2000; 25(5):452-8. PubMed ID: 11009229
[TBL] [Abstract][Full Text] [Related]
5. Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo.
Warncke T; Stubhaug A; Jørum E
Pain; 1997 Aug; 72(1-2):99-106. PubMed ID: 9272793
[TBL] [Abstract][Full Text] [Related]
6. The effect of naloxone on ketamine-induced effects on hyperalgesia and ketamine-induced side effects in humans.
Mikkelsen S; Ilkjaer S; Brennum J; Borgbjerg FM; Dahl JB
Anesthesiology; 1999 Jun; 90(6):1539-45. PubMed ID: 10360849
[TBL] [Abstract][Full Text] [Related]
7. Preinjury treatment with morphine or ketamine inhibits the development of experimentally induced secondary hyperalgesia in man.
Warncke T; Stubhaug A; Jørum E
Pain; 2000 Jun; 86(3):293-303. PubMed ID: 10812259
[TBL] [Abstract][Full Text] [Related]
8. The effect of Ketamine on stimulation of primary and secondary hyperalgesic areas induced by capsaicin--a double-blind, placebo-controlled, human experimental study.
Andersen OK; Felsby S; Nicolaisen L; Bjerring P; Jensen TS; Arendt-Nielsen L
Pain; 1996 Jul; 66(1):51-62. PubMed ID: 8857631
[TBL] [Abstract][Full Text] [Related]
9. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects.
Park KM; Max MB; Robinovitz E; Gracely RH; Bennett GJ
Pain; 1995 Nov; 63(2):163-172. PubMed ID: 8628581
[TBL] [Abstract][Full Text] [Related]
10. NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride.
Felsby S; Nielsen J; Arendt-Nielsen L; Jensen TS
Pain; 1996 Feb; 64(2):283-291. PubMed ID: 8740606
[TBL] [Abstract][Full Text] [Related]
11. Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine--a double-blind, cross-over comparison with alfentanil and placebo.
Jørum E; Warncke T; Stubhaug A
Pain; 2003 Feb; 101(3):229-235. PubMed ID: 12583865
[TBL] [Abstract][Full Text] [Related]
12. The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methyl-D-aspartate receptor.
Willert RP; Woolf CJ; Hobson AR; Delaney C; Thompson DG; Aziz Q
Gastroenterology; 2004 Mar; 126(3):683-92. PubMed ID: 14988822
[TBL] [Abstract][Full Text] [Related]
13. [Suppressive effects of ketamine on neuropathic pain].
Sonoda H; Omote K
Masui; 1998 Feb; 47(2):136-44. PubMed ID: 9513324
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Nefopam Infusion during Laparascopic Cholecystectomy on Postoperative Pain.
Kim EM; Jeon JH; Chung MH; Choi EM; Baek SH; Jeon PH; Lee MH
Int J Med Sci; 2017; 14(6):570-577. PubMed ID: 28638273
[No Abstract] [Full Text] [Related]
15. The effects of ketamine on the temporal summation (wind-up) of the R(III) nociceptive flexion reflex and pain in humans.
Guirimand F; Dupont X; Brasseur L; Chauvin M; Bouhassira D
Anesth Analg; 2000 Feb; 90(2):408-14. PubMed ID: 10648330
[TBL] [Abstract][Full Text] [Related]
16. S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers.
Sigtermans M; Dahan A; Mooren R; Bauer M; Kest B; Sarton E; Olofsen E
Anesthesiology; 2009 Oct; 111(4):892-903. PubMed ID: 19741495
[TBL] [Abstract][Full Text] [Related]
17. [Low doses ketamine: antihyperalgesic drug, non-analgesic].
Richebé P; Rivat C; Rivalan B; Maurette P; Simonnet G
Ann Fr Anesth Reanim; 2005; 24(11-12):1349-59. PubMed ID: 16115745
[TBL] [Abstract][Full Text] [Related]
18. Local treatment with the N-methyl-D-aspartate receptor antagonist ketamine, inhibit development of secondary hyperalgesia in man by a peripheral action.
Warncke T; Jørum E; Stubhaug A
Neurosci Lett; 1997 May; 227(1):1-4. PubMed ID: 9178844
[TBL] [Abstract][Full Text] [Related]
19. Topically administered ketamine reduces capsaicin-evoked mechanical hyperalgesia.
Pöyhiä R; Vainio A
Clin J Pain; 2006 Jan; 22(1):32-6. PubMed ID: 16340591
[TBL] [Abstract][Full Text] [Related]
20. [Ketamine as an NMDA receptor antagonist].
Kushikata T; Hirota K
Masui; 2013 Jan; 62(1):38-43. PubMed ID: 23431892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
